Cancer of Unknown Primary Site
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB16417 | Geptanolimab | 1 | Completed | 1 |
| DB11363 | Alectinib | 2 | Active Not Recruiting | 1 |
| DB11595 | Atezolizumab | 2 | Active Not Recruiting | 1 |
| DB00112 | Bevacizumab | 2 | Active Not Recruiting | 1 |
| DB01101 | Capecitabine | 2 | Completed | 1 |
| DB00958 | Carboplatin | 2 | Active Not Recruiting | 1 |
| DB00515 | Cisplatin | 2 | Active Not Recruiting | 1 |
| DB05239 | Cobimetinib | 2 | Active Not Recruiting | 1 |
| DB11986 | Entrectinib | 2 | Active Not Recruiting | 1 |
| DB00530 | Erlotinib | 2 | Active Not Recruiting | 1 |
| DB00441 | Gemcitabine | 2 | Active Not Recruiting | 1 |
| DB09257 | Gimeracil | 2 | Completed | 1 |
| DB11743 | Ipatasertib | 2 | Active Not Recruiting | 1 |
| DB06186 | Ipilimumab | 2 | Unknown Status | 1 |
| DB14568 | Ivosidenib | 2 | Active Not Recruiting | 1 |
| DB09035 | Nivolumab | 2 | Unknown Status | 1 |
| DB09074 | Olaparib | 2 | Active Not Recruiting | 1 |
| DB03209 | Oteracil | 2 | Completed | 1 |
| DB01229 | Paclitaxel | 2 | Active Not Recruiting | 1 |
| DB09037 | Pembrolizumab | 2 | Active Not Recruiting | 1 |
| DB15102 | Pemigatinib | 2 | Active Not Recruiting | 1 |
| DB06366 | Pertuzumab | 2 | Active Not Recruiting | 1 |
| DB15765 | Sintilimab | 2 | Active Not Recruiting | 1 |
| DB09256 | Tegafur | 2 | Completed | 1 |
| DB00072 | Trastuzumab | 2 | Active Not Recruiting | 1 |
| DB08881 | Vemurafenib | 2 | Active Not Recruiting | 1 |
| DB08828 | Vismodegib | 2 | Active Not Recruiting | 1 |